Reumatoloxía
Servizo
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (168)
2024
-
Childhood-Onset Non-Infectious Uveitis in the “Biologic Era”. Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings
Ocular Immunology and Inflammation
-
Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry
Arthritis Research and Therapy, Vol. 26, Núm. 1
-
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Real-world data from the BIOBADASER registry
Annals of the Rheumatic Diseases
-
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Lupus Science and Medicine, Vol. 11, Núm. 1
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
Advances in Rheumatology, Vol. 63, Núm. 1
-
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
Musculoskeletal Care, Vol. 21, Núm. 1, pp. 189-197
-
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 61
-
Proposal for updating the Health Assessment Questionnaire
Reumatologia Clinica, Vol. 19, Núm. 5, pp. 266-272
-
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology
Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81
2022
-
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
Seminars in Arthritis and Rheumatism, Vol. 52
-
Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study
Rheumatology (Oxford, England), Vol. 62, Núm. 1, pp. 217-224
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies
RMD open, Vol. 8, Núm. 1
-
Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology
Reumatologia Clinica, Vol. 18, Núm. 5, pp. 253-259
-
Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry
Musculoskeletal Care, Vol. 20, Núm. 2, pp. 403-407
2021
-
Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: A systematic review
Immunotherapy, Vol. 13, Núm. 5, pp. 433-458
-
Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression
Frontiers in Medicine, Vol. 8
-
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Clinical and Experimental Rheumatology, Vol. 39, Núm. 3, pp. 555-563